“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?

A central question in the assessment of benefit/harm of new treatments is: how does the average outcome on the new treatment (the factual) compare to the average outcome had patients received no treatment or a different treatment known to be effective (the counterfactual)? Randomized controlled tria...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Pharmacol Ther
Main Authors: Eichler, H‐G, Bloechl‐Daum, B, Bauer, P, Bretz, F, Brown, J, Hampson, LV, Honig, P, Krams, M, Leufkens, H, Lim, R, Lumpkin, MM, Murphy, MJ, Pignatti, F, Posch, M, Schneeweiss, S, Trusheim, M, Koenig, F
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
State of the Art
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114686/
https://ncbi.nlm.nih.gov/pubmed/27650716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.515
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki